tHEORetically Speaking
Insights, observations, and executive interviews that discuss data and evidence to guide value-based decisions in health care. For more, visit our blog: https://healtheconomics.com/theoretically-speaking/
tHEORetically Speaking
Weekly News Roundup – Medicaid Deals, Oncology Innovation, and Market Tensions Abroad
•
HealthEconomics.com
•
Season 4
•
Episode 17
This week’s tHEORetically Speaking News Roundup covers Pfizer’s new Medicaid pricing deal with the current administration, Cartography Biosciences’ $67M raise to advance its next-generation colorectal cancer therapy, and calls for a U.K. anticompetition probe into pharma investment freezes.
Tune in for this concise recap of the key HEOR, RWE, and Market Access headlines shaping our industry.